Related references
Note: Only part of the references are listed.A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex
Vera P. Krymskaya et al.
RESPIRATORY MEDICINE (2020)
A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/PRDX3 axis in renal cell carcinoma
Rui Yu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases
Gyeyeong Kong et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Lipid Metabolism in Macrophages: Focus on Atherosclerosis
Vasily N. Sukhorukov et al.
BIOMEDICINES (2020)
Resveratrol-induced brown fat-like phenotype in 3T3-L1 adipocytes partly via mTOR pathway
Zihui Liu et al.
FOOD & NUTRITION RESEARCH (2020)
Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness
J. Chris Kingswood et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
CT characteristics predict the response to everolimus or sirolimus of renal angiomyolipomas in patients with tuberous sclerosis complex
Wenda Wang et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
miR-9-5p, miR-124-3p, and miR-132-3p regulate BCL2L11 in tuberous sclerosis complex angiomyolipoma
Yi Cai et al.
LABORATORY INVESTIGATION (2018)
Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial
Yi Cai et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Observational study of characteristics and clinical outcomes of Dutch patients with tuberous sclerosis complex and renal angiomyolipoma treated with everolimus
Bernard A. Zonnenberg et al.
PLOS ONE (2018)
TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy
Heng-Jia Liu et al.
JCI INSIGHT (2018)
CircRNA: functions and properties of a novel potential biomarker for cancer
Shujuan Meng et al.
MOLECULAR CANCER (2017)
Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40
Haijuan Yang et al.
NATURE (2017)
Assessment of Tuberous Sclerosis Complex Associated With Renal Lesions by Targeted Next-generation Sequencing in Mainland China
Yi Cai et al.
UROLOGY (2017)
Circular RNAs: a new frontier in the study of human diseases
Yonghua Chen et al.
JOURNAL OF MEDICAL GENETICS (2016)
Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML)
Anil Kapoor et al.
UROLOGY (2016)
Tuberous sclerosis complex
Elizabeth P. Henske et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Pharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosis
Elena N. Atochina-Vasserman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Retrospective Review of Combined Sirolimus and Simvastatin Therapy in Lymphangioleiomyomatosis
Angelo M. Taveira-DaSilva et al.
CHEST (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Molecular Basis of Giant Cells in Tuberous Sclerosis Complex
David J. Kwiatkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)
Anil J. Trindade et al.
PLOS ONE (2013)
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
Darcy A. Krueger et al.
PEDIATRIC NEUROLOGY (2013)
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
Hope Northrup et al.
PEDIATRIC NEUROLOGY (2013)
mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Timothy R. Peterson et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function
Kai Yang et al.
NATURE IMMUNOLOGY (2011)
RankAggreg, an R package for weighted rank aggregation
Vasyl Pihur et al.
BMC BIOINFORMATICS (2009)
Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas
Shaowei Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Share Paper
